- Last edited on October 27, 2023
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
cl:2-major-neurocog-disorder [on March 20, 2019] |
cl:2-major-neurocog-disorder [on September 13, 2020] |
||
---|---|---|---|
Line 1: | Line 1: | ||
- | ~~NOTOC~~ | ||
====== Major Neurocognitive Disorder ====== | ====== Major Neurocognitive Disorder ====== | ||
+ | {{INLINETOC}} | ||
+ | |||
+ | ===== Primer ===== | ||
+ | |||
+ | == Epidemiology == | ||
+ | The dementia subtypes contributing to major neurocognitive disorder is estimated to be 31.3% [[geri:dementia:alzheimers|Alzheimer's dementia]], 21.9% [[geri:dementia:vascular|vascular dementia]], 10.9% [[geri:dementia:lewy-body|Lewy body dementia]], and 7.8% [[geri:dementia:frontotemporal|frontotemporal dementia]].[([[https://pubmed.ncbi.nlm.nih.gov/11872521/|Stevens, T. I. M., Livingston, G., Kitchen, G., Manela, M., Walker, Z., & Katona, C. (2002). Islington study of dementia subtypes in the community. The British Journal of Psychiatry, 180(3), 270-276.]])] | ||
+ | |||
+ | == Prognosis == | ||
+ | |||
+ | == Comorbidity == | ||
+ | |||
+ | == Risk Factors == | ||
===== Diagnostic Criteria ===== | ===== Diagnostic Criteria ===== | ||
<WRAP group> | <WRAP group> | ||
<WRAP half column> | <WRAP half column> | ||
- | ==== Criterion A ==== | + | == Criterion A == |
- | Evidence of **//significant//** cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) based on: | + | Evidence of **//significant//** cognitive decline from a previous level of performance in ''1'' or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) based on: |
- Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and | - Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and | ||
- A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment. | - A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment. | ||
- | ==== Criterion B ==== | + | == Criterion B == |
The cognitive deficits **//interfere with independence in everyday activities//** (i.e., at a minimum, requiring assistance with complex instrumental activities of daily living such as paying bills or managing medications). | The cognitive deficits **//interfere with independence in everyday activities//** (i.e., at a minimum, requiring assistance with complex instrumental activities of daily living such as paying bills or managing medications). | ||
- | ==== Criterion C ==== | + | == Criterion C == |
The cognitive deficits do not occur exclusively in the context of a delirium. | The cognitive deficits do not occur exclusively in the context of a delirium. | ||
- | ==== Criterion D ==== | + | == Criterion D == |
The cognitive deficits are not better explained by another mental disorder (e.g., [[mood:1-depression:home|major depressive disorder]], [[psychosis:schizophrenia-scz|schizophrenia]]). | The cognitive deficits are not better explained by another mental disorder (e.g., [[mood:1-depression:home|major depressive disorder]], [[psychosis:schizophrenia-scz|schizophrenia]]). | ||
</WRAP> | </WRAP> |